They also show promise for the treatment of many inflammatory diseases including asthma and inflammatory bowel disorders like Crohns disease and ulcerative colitis Diagram showing food stimulating the release of GLP-1 into the intestine and its effects on the brain, stomach and pancreas Importance In 2023 GLP-1 based drugs was named breakthrough of the year by Science , a prestigious American journal
8,9,31,32 These trials provided the first signs of the benefit of GLP-1RAs in HF
GLP-1 inhibits glucagon secretion when plasma glucose concentration is high, while GIP acts at lower glucose levels
That said, everyones body responds differently and results depend on lifestyle, metabolism, and the amount of fat being treated
At a dose of 10 nmol kg 1 GLP-1RA/tesaglitazar showed slightly superior efficacy at improving glucose control (Fig